REGENT ASSISTED LIVING INC
DEF 14A, 2000-04-27
SKILLED NURSING CARE FACILITIES
Previous: AMERIPRIME FUNDS, 497, 2000-04-27
Next: ECHOSTAR COMMUNICATIONS CORP, 10-Q, 2000-04-27



                          REGENT ASSISTED LIVING, INC.

                        Bank of America Financial Center
                      121 S.W. Morrison Street, Suite 1000
                             Portland, Oregon 97204


                    NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
                           TO BE HELD ON May 23, 2000


To Our Shareholders:

         The Annual Meeting of Shareholders of Regent Assisted Living, Inc. (the
"Company")  will be held at 11:00 a.m. on  Tuesday,  May 23,  2000,  at the U.S.
Bancorp Tower,  111 S.W. Fifth Avenue,  30th Floor,  Portland,  Oregon,  for the
following purposes:

         1.   Electing two directors of the Company for a term of three years;

         2.   Amending the Company's  1995 Stock  Incentive Plan to increase the
              number of shares of the Company's  Common Stock that may be issued
              pursuant to the Plan from 600,000 to 800,000; and

         3.   Transacting  such other  business as may properly  come before the
              meeting.

         Only holders of the Company's  Common and Preferred  Stock at the close
of business on Friday,  March 31,  2000,  are entitled to notice of, and to vote
at, the meeting and any adjournments or postponements thereof.  Shareholders may
vote in person  or by  proxy.  A list of  shareholders  entitled  to vote at the
meeting will be available for  examination by shareholders at the time and place
of the meeting and, on or after May 1, 2000,  at the offices of the Secretary of
the Company, Suite 1000, 121 S.W. Morrison Street, Portland, Oregon.

                                            By Order of the Board of Directors,



                                            David R. Gibson
                                            Secretary

YOUR VOTE IS IMPORTANT.  WHETHER OR NOT YOU EXPECT TO ATTEND THE ANNUAL  MEETING
IN PERSON,  PLEASE  MARK,  SIGN,  DATE,  AND  PROMPTLY  RETURN YOUR PROXY IN THE
ENCLOSED ENVELOPE.

Portland, Oregon
April 28, 2000


<PAGE>

                          REGENT ASSISTED LIVING, INC.
                        Bank of America Financial Center
                      121 S.W. Morrison Street, Suite 1000
                             Portland, Oregon 97204

                       ----------------------------------
                                 PROXY STATEMENT

                       2000 Annual Meeting of Shareholders
                       ----------------------------------


         This Proxy Statement is furnished in connection  with the  solicitation
by the Board of Directors of Regent  Assisted  Living,  Inc. (the  "Company") of
proxies to be voted at the 2000 Annual Meeting of Shareholders of the Company to
be held at 11:00 a.m. on Tuesday,  May 23, 2000, at the U.S.  Bancorp Tower, 111
S.W. Fifth Avenue,  30th Floor,  Portland,  Oregon,  and at any  adjournments or
postponements  thereof.  If  proxies  in  the  accompanying  form  are  properly
executed,  dated and returned prior to the voting at the meeting,  the shares of
Common Stock represented thereby will be voted as instructed on the proxy. If no
instructions are given on a properly  executed and returned proxy, the shares of
Common Stock represented thereby will be voted for election of the directors and
in the  discretion of the persons  named in the proxy on such other  business as
may  properly  come  before the  meeting or any  adjournments  or  postponements
thereof.

         Any proxy may be revoked by a  shareholder  prior to its exercise  upon
written  notice to the  Secretary of the Company,  by delivering a duly executed
proxy bearing a later date,  or by the vote of a  shareholder  cast in person at
the meeting.  The cost of  soliciting  proxies will be borne by the Company.  In
addition to  solicitation  by mail,  proxies may be solicited  personally by the
Company's officers and regular employees or by telephone, facsimile transmission
or express mail. The Company will reimburse  brokerage  houses,  banks and other
custodians,  nominees and fiduciaries for their reasonable  expenses incurred in
forwarding  proxies and proxy material to beneficial owners of stock. This Proxy
Statement and the accompanying Notice of Annual Meeting and proxy card are first
being mailed to shareholders on or about May 5, 2000

                                     VOTING

         Holders of record of the Company's  Common Stock  ("Common  Stock") and
Series A Preferred  Stock ("Series A Preferred  Stock") at the close of business
on Friday,  March 31, 2000, will be entitled to notice of the Annual Meeting and
to vote at the Annual Meeting or any adjournments or postponements  thereof.  As
of that date,  there were 4,507,600 shares of Common Stock, and 1,283,785 shares
of Series A Preferred Stock,  outstanding and entitled to vote. As of that date,
there  were  also  382,882  shares of the  Company's  Series B  Preferred  Stock
("Series B Preferred Stock") outstanding,  which shares are not entitled to vote
on the matters  expected to be presented at the Annual  Meeting and are entitled
to vote only on  specific  categories  of matters as set forth in the  Company's
Restated Articles of  Incorporation,  as amended (the "Restated  Articles").  On
those  matters on which the holders of Series B Preferred  Stock are entitled to
vote,  they vote  together with the holders of the Common Stock and the Series A
Preferred Stock as a single class. Pursuant to the Restated Articles, the shares
of  Common  Stock  are each  entitled  to one vote and the  shares  of  Series A
Preferred Stock are each entitled to 1.0909 votes. The Common Stock and Series A
Preferred  Stock vote as a single class on the matters  expected to be presented
at the  Annual  Meeting.  A  majority  of the votes  entitled  to be cast by the
holders of Common Stock and Series A Preferred Stock, or 2,954,041  votes,  will
constitute a quorum to act on the matters expected to be presented at the Annual
Meeting.

                                       1
<PAGE>

         Shareholders  are not entitled to cumulative  voting in the election of
directors or on any other matter  submitted to the  shareholders  for  approval.
Abstentions and broker non-votes will be counted in determining whether a quorum
is present,  but  otherwise  will have no effect on the outcome of any  proposal
considered at the meeting. Walter C. Bowen, Chairman of the Board, President and
Chief Executive Officer of the Company, owns or controls 3,403,200 shares of the
Company's  Common Stock,  representing  57.6 percent of the votes entitled to be
cast at the meeting,  and he has indicated  that he intends to be present at the
meeting and to vote in favor of each of the nominees for director.  Accordingly,
the Company believes that approval of each of the two proposals  discussed below
is assured.

PROPOSAL 1. Election of two directors of the Company for a term of three years.

         The Company's  Bylaws  provide for a Board of Directors  comprised of a
maximum of eight  directors.  Currently,  the Company has seven  directors.  The
directors  are divided  into three  classes:  Class I which is  comprised of two
directors;  Class II which is comprised of three  directors,  but currently only
two are  serving;  and Class  III which is  comprised  of three  directors.  Two
directors are to be elected at the upcoming  Annual Meeting of  Shareholders  to
fill all of the  directorships  in Class I.  Thereafter,  the term of  office of
Class I will  expire at the 2003  Annual  Meeting of  Shareholders.  The term of
office of Class II will expire at the 2001 Annual  Meeting of  Shareholders  and
the term of office  of Class  III will  expire  at the 2002  Annual  Meeting  of
Shareholders.

         Under  Oregon law, if a quorum of  shareholders  is present at the 2000
Annual  Meeting,  the two nominees  for  election of  directors  who receive the
greatest  number  of  votes  cast  at the  meeting  will be  elected  directors.
Abstentions and broker non-votes will have no effect on the results of the vote.
Unless marked otherwise, proxies received will be voted FOR the election of each
of the nominees named below.

         If any  nominee  is unable or  unwilling  to stand  for  election,  the
proxies may be voted for a substitute  nominee,  designated by the proxy holders
or by the  present  Board of  Directors  to fill such  vacancy,  or for  another
nominee named without nomination of a substitute, or the number of directors may
be reduced accordingly. The Board of Directors has no reason to believe that any
of the nominees will be unwilling or unable to serve if elected as a director.

The Board of Directors recommends a vote FOR each of the nominees named below.

         Steven  L.  Gish has  served  as Chief  Financial  Officer,  Treasurer,
         Secretary, and Assistant Secretary in addition to serving as a Director
         of the  Company,  since  August  1995.  In 1991  Mr.  Gish  became  the
         Controller  of  the  "Bowen   Companies,"  a  group  of  companies  and
         businesses owned or controlled by Mr. Bowen,  including the predecessor
         of the Company.  Prior to that time,  Mr. Gish served as Treasurer  and
         Controller of McCormick and Baxter  Creosoting  Company,  an industrial
         wood preserving company.

         Dana J. O'Brien is a Senior  Managing  Director of  Cornerstone  Equity
         Investors,  L.L.C., a New York-based investment firm formed in December
         1996 to provide  investment  management  services to several investment
         funds.  Cornerstone  is the  investment  advisor to Prudential  Private
         Equity  Investors III, L.P., the holder of all of the Company's  issued
         and outstanding Series A and Series B Preferred Stock.  During the five
         year period  preceding  December  1996, Mr. O'Brien served as Executive
         Vice  President of  Prudential  Equity  Investors,  Inc., an investment
         management firm. Mr. O'Brien currently serves on the Board of Directors
         of several private companies, including Specialty Hospitals of America,
         Inc.  and Guardian  Care,  Inc.  Mr.  O'Brien  became a director of the
         Company in December 1996.



                                       2
<PAGE>

Directors whose terms continue:

Class II:

                  Stephen A. Gregg is a former hospital  administrator and began
         serving as a director of the Company on December  16,  1996.  Mr. Gregg
         was the founder and chief executive officer of The Ethix Corporation, a
         managed   care  company   serving   approximately   5,000,000   members
         nationwide,  prior to its sale in 1994.  Mr.  Gregg  currently  manages
         personal investments.

                  Wayne  C.  Rembold  was  elected  a  director  of the  Company
         effective  March 17, 1999.  For the past 30 years Mr.  Rembold has been
         involved in  numerous  types of real estate  development  ventures  and
         business activities. Since 1994 Mr. Rembold has served as the President
         and Chief Executive Officer of the Rembold Companies, which are engaged
         in the  development  of retail and warehouse  facilities in addition to
         manufactured home parks and multi-family housing projects.

Class III:

                  Walter C. Bowen has served as  Chairman of the Board and Chief
         Executive  Officer and a director of the Company since its formation in
         March 1995.  Mr. Bowen also served as  President  of the Company  until
         October 31,  1999.  Mr.  Bowen has been  involved  in the  development,
         ownership, and management of assisted living facilities since 1986, and
         has devoted a majority of his time to the  ownership  and  operation of
         those facilities over the past five years. Mr. Bowen continues to serve
         as the Chief Executive Officer of the Bowen Companies.

                  Marvin  S.  Hausman,  M.D.  has  served as a  director  of the
         Company since March 1996. Dr. Hausman is a founder and is President and
         Chief Executive Officer of Axonyx Inc., a biotechnology company engaged
         in the  development  and  acquisition of  pharmaceutical  compounds and
         technologies  useful for the treatment of cognitive disorders including
         Alzheimer's disease. Since 1992, Dr. Hausman has served as a consultant
         to the  pharmaceutical  industry  and since 1995 he has also  served as
         President  of  Northwest  Medical  Research  Partners,  Inc., a company
         engaged  in  evaluating  biopharmaceutical   technologies  and  medical
         devices.

                  Gary R. Maffei has served as a director  of the Company  since
         December  1995.  Mr. Maffei is currently a Vice  President of the Merlo
         Corporation,   a  private  investment  company,  and  the  Harry  Merlo
         Foundation,  Inc., a charitable  organization.  From 1973 until joining
         these companies in 1996, Mr. Maffei was the Director of Human Resources
         for Louisiana Pacific Corporation, a forest products company.

         The following  table sets forth certain  information  about each of the
Company's Directors, including the two nominees.

               Name                    Age   Class and  Term    Director Since
- -------------------------------------  ---   ---------------    --------------
Nominees:
         Dana J. O'Brien (1)(2)(3)(4)  44    (Class I,  2000)   December 1996
         Steven L. Gish                41    (Class I,  2000)   August 1995


                                       3
<PAGE>

Directors whose terms continue:

         Wayne C. Rembold (3)          58    (Class II, 2001)   March 1999
         Stephen A. Gregg (1)(4)       55    (Class II, 2001)   December 1996
         Walter C. Bowen(1)(2)         57    (Class III, 2002)  March 1995
         Marvin S. Hausman, MD         58    (Class III, 2002)  March 1996
         Gary R. Maffei (2)(4)         55    (Class III, 2002)  December 1995

         (1)  Member of Executive Committee
         (2)  Member of Compensation Committee
         (3)  Member of Audit Committee
         (4)  Member of Conflicts Committee

Information on Committees of the Board of Directors and Meetings

         During 1999,  there were five meetings of the Board of  Directors.  Mr.
Maffei and Dr.  Hausman each  attended  three of the five meetings and all other
directors attended all meetings.  All Board members attended at least 75 percent
of the meetings of each committee of which he or she was a member.  The Board of
Directors also took action by unanimous written consent,  in accordance with the
Company's Bylaws, on three occasions in 1999.

         The  Company's   Board  of  Directors  has   established  an  Executive
Committee, Audit Committee, Compensation Committee, and Conflicts Committee. The
Company has no  Nominating  Committee  and the full Board of  Directors  selects
nominees for election as directors.

         The Executive Committee acts on all matters requiring  consideration by
the Board in the interim period between regular and special Board meetings.  The
Executive  Committee  currently  consists of Messrs.  Bowen,  Gregg and O'Brien.
Martha Robinson,  a former  independent  Director of the Company,  served on the
Committee  during 1999.  In 1999 the  Executive  Committee met one time and took
action by written consent on three occasions.

         The Compensation  Committee establishes salaries,  incentives and other
forms of  compensation  for  directors,  officers and other key employees of the
Company,  administers  the 1995 Stock  Incentive  Plan, and recommends  policies
relating to benefit plans. The Compensation  Committee currently consists of Mr.
Bowen and two independent  directors,  Messrs.  O'Brien and Maffei. In 1999, the
Compensation Committee took action by written consent on three occasions.

         The Audit Committee makes recommendations  concerning the engagement of
independent public accountants,  reviews with the independent public accountants
the scope and  results  of the audit,  reviews  management's  evaluation  of the
Company's  system of  internal  controls,  and  reviews  non-audit  professional
services  provided  by the  independent  accountants  and the range of audit and
non-audit  fees.  The Audit  Committee  will  also  review,  at least  annually,
reimbursement of costs by the Company and the other Bowen Companies  pursuant to
the Administrative  Services Agreement.  See "Certain  Relationships and Related
Party  Transactions." The Audit Committee  currently consists of two independent
directors,   Messrs.  Mr.  Rembold  and  O'Brien.   Martha  Robinson,  a  former
independent  Director of the Company,  served on the Committee  during 1999. The
Audit Committee met twice in 1999.

         The Conflicts Committee,  consisting of four independent directors,  is
responsible for considering for approval on behalf of the Board of Directors all
transactions  between  the Company and any officer or director of the Company or
any entity in which such  officer or director  has an  equitable  or  beneficial
interest. The Conflicts Committee currently consists of Messrs.  O'Brien, Gregg,
and Maffei.  Martha  Robinson,  a former  independent  Director of the  Company,
served on


                                       4
<PAGE>

the Committee  during 1999.  The Conflicts  Committee met twice in 1999 and took
action by written consent on two other occasions.

Compensation of Directors

         The Company pays each  non-employee  director  $500 for  attendance  in
person at each  regular  meeting of the Board of  Directors.  In  addition,  the
Company will reimburse the directors for travel expenses  incurred in connection
with their activities on behalf of the Company.

         Each  non-employee  member of the Board of  Directors of the Company is
automatically  granted an option to purchase  2,000  shares of Common Stock when
that person becomes a director. Each non-employee director is also automatically
granted an option to purchase  2,000  additional  shares of Common Stock in each
subsequent  calendar year that the director continues to serve in that capacity.
The exercise price for all automatic  grants to  non-employee  directors will be
the closing  sales price of the Common  Stock on the  business  day  immediately
preceding the date of grant.


PROPOSAL 2: Amendment to the Company's 1995 Stock Incentive Plan to increase the
number of shares of the  Company's  Common Stock that may be issued  pursuant to
the Plan from 600,000 to 800,000.

         The purpose of the Company's 1995 Stock  Incentive Plan (the "Plan") is
to enable the Company to attract and retain the services of selected  employees,
officers  and  directors  of  the  Company  and  selected   nonemployee  agents,
consultants,  advisors and  independent  contractors  of the  Company.  The Plan
provides for the award of incentive stock options to key employees and the award
of non-statutory  stock options,  stock  appreciation  rights,  bonus rights and
other  incentive   grants  to  employees,   officers,   directors,   independent
contractors and consultants.  Currently,  600,000 shares of the Company's Common
Stock are  authorized  to be issued  pursuant to the Plan. As of March 31, 2000,
options to purchase 579,000 shares had been granted to officers and employees of
the Company, directors, and one independent consultant pursuant to the Plan.

         The Board of Directors believes  additional shares must be reserved for
use under the Plan to enable the Company to attract and retain key employees and
to provide  appropriate  incentives  to key  employees and others to exert their
best efforts on behalf of the Company. Stock options are currently the principal
long-term  compensation  element  of the  Company's  officer  and  key  employee
compensation.  Accordingly, on March 7, 2000, the Board of Directors approved an
amendment to the Plan, subject to shareholder approval, to reserve an additional
200,000  shares for the Plan,  thereby  increasing the total number of shares of
the Company's  Common Stock reserved for issuance under the Plan from 600,000 to
800,000. In addition,  shareholder approval of this Proposal 2 will constitute a
reapproval  of  the   per-employee   limits  on  grants  of  options  and  stock
appreciation rights under the Plan of 100,000 shares for new hires and otherwise
50,000 shares annually.

Recommendation by the Board of Directors

         The Board of Directors  recommends  that the proposed  amendment to the
Plan be  approved.  The  affirmative  vote of the  holders of a majority  of the
shares of Common Stock and Series A Preferred Stock present and entitled to vote
on the matter at the Annual  Meeting is  required  to approve  this  Proposal 2.
Accordingly,  abstentions  have the same  effect  as "no"  votes in  determining
whether the amendment is approved.  Broker non-votes are counted for purposes of
determining  whether a quorum  exists at the Annual  Meeting but are not counted
and have no effect on the results of the vote on Proposal 2. The proxies will be
voted for or against the


                                       5
<PAGE>

proposal or as an abstention,  in accordance with the instructions  specified on
the proxy form. If no instructions are given, proxies will be voted for approval
of the amendment to the Plan.


                    DESCRIPTION OF 1995 STOCK INCENTIVE PLAN

         In August  1995,  the  Company's  Board of  Directors  adopted  and its
shareholders  subsequently approved the Company's 1995 Stock Incentive Plan (the
"Plan"),  which  provides  for the  award  of  incentive  stock  options  to key
employees  and the award of  non-statutory  stock  options,  stock  appreciation
rights,  bonus  rights  and  other  incentive  grants  to  employees,  officers,
directors, independent contractors, and consultants.

         Eligibility.  Awards may be granted under the Plan to those  employees,
officers and  directors of the Company who the Board of Directors  believes have
made or will make an important  contribution to the Company.  As of December 31,
1996,  the  Company  had   approximately  365  employees  and  six  non-employee
directors.  Non-employee  consultants  and  advisors  to the  Company  are  also
eligible to participate in the Plan.

         Administration.  The Plan is  administered  by the Board of  Directors,
which has the  authority,  subject to the terms of the Plan,  to  determine  the
persons  to whom  awards  may be  granted,  the amount of any such award and the
price  and  other  terms  and  conditions  of any  such  award.  Subject  to the
provisions  of the Plan,  the Board  may adopt and amend  rules and  regulations
relating to the  administration of the Plan and may delegate to the Compensation
Committee of the Board of Directors  general authority for making option grants.
However, only the Board of Directors may amend, modify or terminate the Plan.

         Shares  Available.  A total of 400,000 shares of Common Stock initially
were  reserved  for  issuance  under the Plan.  At the 1997  annual  meeting  of
shareholders,  the  shareholders  approved a proposal to increase to 600,000 the
number of shares  available  under the Plan.  As of March 31,  2000,  options to
purchase a total of 579,000 shares had been granted to officers and employees of
the Company,  directors,  and one independent  consultant  pursuant to the Plan,
leaving  21,000  shares  available  for  future  grants.  If  an  option,  stock
appreciation   right  or  performance  unit  granted  under  the  Plan  expires,
terminates or is canceled, or if shares sold or awarded as a bonus are forfeited
to or repurchased by the Company, the shares again become available for issuance
under the Plan.

         Term of the Plan. The Plan will continue until all shares available for
issuance  under the Plan have been  issued and all  restrictions  on such shares
have  lapsed.  The Board of Directors  may suspend or terminate  the Plan at any
time except with  respect to options,  performance  units and shares  subject to
restrictions then outstanding under the Plan.

         Stock  Options.  The Board  determines  the persons to whom options are
granted,  the option  price,  the number of shares  subject to each option,  the
period of each option,  the times at which  options may be exercised and whether
the option is an Incentive  Stock Option  ("ISO"),  as defined in Section 422 of
the Internal  Revenue Code of 1986, as amended (the "Code"),  or an option other
than an ISO (a "Non-Statutory  Stock Option" or "NSO"). If the option is an ISO,
the option  price may not be less than the fair market value of the Common Stock
subject to the ISO on the date of grant. If an optionee of an ISO at the time of
grant owns more than 10 percent of the outstanding  Common Stock of the Company,
the option  price may not be less than 110 percent of the fair  market  value of
the Common  Stock  subject to the ISO on the date of grant.  If the option is an
NSO, the option price may be any price  determined  by the Board.  No ISO may be
granted on or after the tenth  anniversary  of the date the Plan was  adopted by
the Board of  Directors.  The aggregate  fair market  value,  on the date of the
grant,  of the stock for which  ISO's are  exercisable  for the first time by an
employee  during  any  calendar  year  may  not  exceed  $100,000.  No  monetary
consideration is paid to the


                                       6
<PAGE>

Company upon the granting of options.  On March 27, 2000, the last sale price of
the Common Stock on the Nasdaq Over-the-Counter Bulletin Board System was $1 per
share.

         Options  granted  under the Plan  generally  continue in effect for the
period  fixed by the  Board,  except  that ISO's are not  exercisable  after the
expiration  of 10 years  from  the  date of  grant or five  years in the case of
shareholders  owning  more than 10  percent  of the Common  Stock.  Options  are
exercisable in accordance with the terms of an option agreement  entered into at
the time of grant and, except as otherwise  determined by the Board with respect
to an NSO  granted to a person who is neither an officer  nor a director  of the
Company,  are  nontransferable  except on the death of a holder.  Options may be
exercised only while an optionee is employed by or in the service of the Company
or within 12 months  following  termination  of employment by reason of death or
disability  or 30 days  following  termination  for any other  reason.  The Plan
provides that the Board may extend the exercise  period for any period up to the
expiration  date of the option and may  increase  the number of shares for which
the option may be exercised up to the total number  underlying  the option.  The
purchase price for each share purchased  pursuant to exercise of options must be
paid in cash,  including,  with the consent of the Board,  cash which may be the
proceeds of a loan from the Company or, with the consent of the Board,  in whole
or in part, in shares of Common Stock valued at fair market value, in restricted
stock, in performance  units or other  contingent  awards  denominated in either
stock or cash, in promissory notes or in other forms of consideration.  Upon the
exercise of an option, the number of shares subject to the option and the number
of shares  available  under the Plan for future option grants are reduced by the
number of shares with respect to which the option is exercised.

         Stock Appreciation  Rights.  Stock appreciation rights ("SAR's") may be
granted under the Plan.  SAR's may, but need not, be granted in connection  with
an option grant or an outstanding  option previously  granted under the Plan. An
SAR gives the holder the right to payment from the Company of an amount equal in
value to the excess of the fair market  value on the date of exercise of a share
of Common  Stock of the Company over its fair market value on the date of grant,
or if granted in connection with an option, the option price per share under the
option to which the SAR relates.

         A SAR is  exercisable  only at the  time or  times  established  by the
Board. If a SAR is granted in connection with an option,  it is exercisable only
to the extent and on the same conditions that the related option is exercisable.
Unless  otherwise  determined  by the  Board,  no SAR  granted  to an officer or
director can be  exercised  during the first six months after the date of grant.
Payment by the Company  upon  exercise of an SAR may be made in Common  Stock of
the Company  valued at its fair market  value,  in cash,  or partly in stock and
partly in cash,  as  determined  by the Board.  The Board may  withdraw  any SAR
granted  under  the Plan at any  time  and may  impose  any  condition  upon the
exercise of an SAR or adopt rules and  regulations  from time to time  affecting
the rights of holders of SAR's. No SAR's have been granted under the Plan.

         The  existence  of SAR's,  as well as certain  bonus  rights  described
below, would require charges to income over the life of the right based upon the
amount of  appreciation,  if any, in the market value of the Common Stock of the
Company over the exercise price of shares subject to exercisable  SAR's or bonus
rights.

         Stock Bonus Awards.  The Board may award Common Stock of the Company as
a stock bonus under the Plan.  The Board may  determine  the  recipients  of the
awards,  the  number of shares to be awarded  and the time of the  award.  Stock
received as a stock bonus is subject to the terms,  conditions and  restrictions
determined by the Board at the time the stock is awarded.

         Restricted  Stock.  The  Plan  provides  that  the  Company  may  issue
restricted stock in amounts,  for consideration,  subject to restrictions and on
terms that the Board determines.



                                       7
<PAGE>

         Cash Bonus Rights. The Board may grant cash bonus rights under the Plan
in connection with (i) options granted or previously granted, (ii) SAR's granted
or previously  granted,  (iii) stock bonuses  awarded or previously  awarded and
(iv) shares sold or  previously  sold under the Plan.  Bonus  rights  granted in
connection  with  options  entitle the  optionee to a cash bonus if and when the
related  option  is  exercised.  The  amount  of  the  bonus  is  determined  by
multiplying  the excess of the total fair  market  value of the shares  acquired
upon the exercise  over the total option price for the shares by the  applicable
bonus  percentage.  The  bonus  percentage  applicable  to any  bonus  right  is
determined  by the Board but may in no event  exceed 75  percent.  Bonus  rights
granted in connection with stock bonuses or restricted  stock purchases  entitle
the recipient to a cash bonus,  in an amount  determined by the Board,  when the
stock is awarded or purchased or any  restrictions to which the stock is subject
lapse. No bonus rights have been granted under the Plan.

         Performance  Units. The Board may grant performance units consisting of
monetary  units which may be earned in whole or in part if the Company  achieves
goals  established by the Board of Directors  over a designated  period of time,
but in any event not more than 10 years.  Payment  of an award  earned may be in
cash or  Common  Stock or both,  and may be made  when  earned,  or  vested  and
deferred, as the Board of Directors  determines.  No performance units have been
granted under the Plan.

         Changes in Capital Structure. The Plan provides that if the outstanding
Common  Stock of the  Company is  increased  or  decreased  or  changed  into or
exchanged  for a different  number or kind of shares or other  securities of the
Company  by  reason  of any  recapitalization,  stock  split  or  certain  other
transactions,  appropriate  adjustment will be made by the Board of Directors in
the number and kind of shares  available for awards under the Plan. In addition,
the Board of Directors will make appropriate  adjustments in outstanding options
and SAR's. In the event of dissolution of the Company or a merger, consolidation
or plan of exchange  affecting the Company,  in lieu of the foregoing  treatment
for options and SAR's, the Board may, in its sole  discretion,  provide a 30-day
period  prior to such  event  during  which  optionees  shall  have the right to
exercise  options  and  SAR's in  whole or in part  without  any  limitation  on
exercisability  and upon the  expiration of which 30-day period all  unexercised
options and SAR's shall immediately terminate.

         Material Federal Income Tax Consequences. Certain options authorized to
be granted  under the Plan are  intended to qualify as ISO's for federal  income
tax  purposes.  Under federal  income tax law currently in effect,  the optionee
will recognize no income upon grant or exercise of the ISO. However,  the amount
by which the market value  exceeds the exercise  price  generally is included in
the  optionee's  alternative  minimum  taxable  income  and may,  under  certain
conditions,  be taxed under the  alternative  minimum tax. If an optionee  holds
shares  acquired upon exercise of an ISO until the later of two years  following
the date of  grant or one year  following  the date of  exercise  (the  "holding
period"), and if the optionee has been employed by the Company (or any parent or
subsidiary of the Company) at all times from the date of grant to the date three
months before  exercise,  then any gain realized upon subsequent  disposition of
the shares generally will be long-term  capital gain and any loss generally will
be long-term  capital  loss.  If an optionee  disposes of shares  acquired  upon
exercise  of an ISO  before  the  expiration  of the  holding  period (an "early
disposition"),  any amount  realized  will be taxable as  ordinary  compensation
income in the year of such disqualifying disposition to the extent of the lesser
of (1) the excess of the fair market value of the shares on the date of exercise
over the  exercise  price,  or (2) the  excess  of the  amount  realized  on the
disposition  over the  optionee's  adjusted  basis in the  shares on the date of
disposition.  The Company will not be allowed any deduction  for federal  income
tax  purposes at either the time of the grant or the time of exercise of an ISO.
Upon any disqualifying disposition by an optionee, the Company generally will be
entitled to a deduction to the extent the optionee  recognizes  ordinary income,
provided the Company reports the disposition as required by the Internal Revenue
Service.



                                       8
<PAGE>

         Certain options authorized to be granted under the Plan will be treated
as NSO's for federal income tax purposes. Under federal income tax law presently
in effect,  no income is realized by the  optionee of an NSO until the option is
exercised.  When the NSO is  exercised,  the optionee  will  recognize  ordinary
compensation  income, and the Company generally will be entitled to a deduction,
in the amount by which the fair market value of the shares subject to the option
at the time of exercise exceeds the exercise price,  and for employee  grantees,
such income is subject to employment  tax and income tax  withholding.  Upon the
sale of shares  acquired  upon  exercise  of an NSO,  the  excess of the  amount
realized from the sale over the adjusted basis of the shares, which generally is
equal to the fair market  value of the shares on the date of exercise  generally
will be taxable to the optionee as capital gain.

         A participant who receives stock (either as a stock bonus or restricted
stock) in connection with the  performance of services  generally will recognize
ordinary  compensation  income at the time of receipt, in an amount equal to the
excess of the fair  market  value of the shares at the time of receipt  over the
amount,  if any,  paid for the  shares,  if either the shares are  substantially
vested for  purposes  of Section 83 of the Code or a Section  83(b)  election is
made. If the shares are not vested at the time of receipt,  the participant will
recognize  ordinary  compensation  income in each year in which a portion of the
shares substantially vest, unless the employee elects under Section 83(b) of the
Code within 30 days after the  original  transfer to include in gross income the
excess of the fair market  value of the shares at transfer  over the amount,  if
any,  paid for the  shares.  The  Company  generally  will be  entitled to a tax
deduction in the amount includable as compensation  income by the participant at
the same time or times as the participant  recognizes income with respect to the
shares.  A participant  who receives a cash bonus right under the Plan generally
will  recognize  ordinary  compensation  income  equal to the amount of any cash
bonus at the time of receipt of the bonus,  and the  Company  generally  will be
entitled to a deduction equal to the income  recognized by the participant.  For
employee participants,  amounts recognized as compensation income are subject to
employment tax and income tax withholding.

         Under federal income tax law currently in effect, no income is realized
by the  grantee  of a SAR  until  the SAR is  exercised.  At the time the SAR is
exercised,  the grantee will recognize  ordinary  compensation  income,  and the
Company  generally  will be entitled to a deduction,  in the amount equal to the
fair market value of the shares or cash  received.  For employee  grantees,  the
amount of  compensation  income is  subject  to  employment  tax and  income tax
withholding.

         In certain  situations  stock  received by persons  who are  "insiders"
under  Section  16(b)  of  the  Securities  Exchange  Act  of  1934  may  not be
"substantially  vested" when received.  Therefore,  the above  discussion  under
"Material  Federal Income Tax Consequences" may not be fully applicable to stock
acquired under the Plan by insiders.

         Section  162(m) of the Code  limits to $1 million per person the amount
the Company may deduct for  compensation  paid to the Company's  chief executive
officer or the four most highly compensated officers in any year beginning after
1993.  Under IRS regulations,  compensation  received through the exercise of an
option or SAR will not be subject  to the $1 million  limit if the option or SAR
meet certain  requirements.  One such  requirement  is  shareholder  approval of
per-employee  limits on the number of shares as to which  options or SARs may be
granted.  Approval  of  this  Proposal  2  will  constitute  reapproval  of  the
per-employee  limits  under the Plan  previously  approved by the  shareholders.
Other requirements are that the option or SAR be granted by a committee composed
solely  of two or more  outside  directors  and that the  exercise  price of the
option or the SAR be not less than the fair  market  value of the  Common  Stock
subject  to the  option or SAR on the date of grant.  Accordingly,  the  Company
believes  that if this  Proposal 2 is  approved  by  shareholders,  compensation
received  on exercise of options or SARs  granted  under the Plan in  compliance
with the above  requirements  will  continue  to be exempt  from the  $1,000,000
deduction limit.


                                       9
<PAGE>

                             EXECUTIVE COMPENSATION

         Summary  Compensation  Table.  The following table sets forth,  for the
fiscal years ended December 31, 1999,  1998, and 1997  compensation  information
with respect to the Company's chief executive  officer and each of its executive
officers  whose  compensation  from the  Company  exceeded  $100,000  during the
relevant fiscal year.

                           Summary Compensation Table

                               Annual Compensation

                                                                  Other Annual
Name and Principal Position     Year        Salary       Bonus  Compensation(1)
- ---------------------------     ----       --------     ------- ---------------

Walter C. Bowen                 1999       $250,000     $  -0-       $1,750
   Chairman of the Board        1998(2)    $250,000     $  -0-       $2,384
   Chief Executive Officer      1997(3)    $200,000     $25,000      $3,000

Louis Swart                     1999(4)    $132,901     $  -0-       $8,830(5)
   President

James W. Ekberg                 1999       $150,000     $  -0-       $1,750
   Senior Vice President        1998       $150,000     $  -0-       $2,384
   of Finance and               1997(3)    $130,000     $  -0-       $3,300
   Development(6)

Eric W. Jacobsen(7)             1999       $101,250     $   -0-      $1,750
   Chief Operating Officer      1998       $135,000     $   -0-      $2,384
                                1997       $115,000     $   -0-      $3,750

Steven L. Gish                  1999       $120,000     $   -0-      $1,750
   Chief Financial Officer      1998(3)    $ 95,000     $   -0-      $2,384
                                1997(3)    $ 85,000     $   -0-      $3,135

(1)      Represents the amount of a contribution by the Company to the officer's
         401(k) plan account.

(2)      Mr. Bowen also served as  President  of the Company from its  inception
         through October 31, 1999.

(3)      Certain  executive  officers of the Company fulfill  similar  executive
         functions for certain of the Bowen  Companies.  A portion of the salary
         expense for these  officers  is  reimbursed  to the  Company  through a
         general  allocation  made  pursuant  to  the  Administrative   Services
         Agreement.  The disclosed salary amount represents the net compensation
         paid by the  Company to the  officer  for the  indicated  period  after
         reimbursement  by the Bowen  Companies for time spent by the officer on
         Bowen Companies business.

(4)      Mr. Swart served as Chief  Operating  Officer of the Company from April
         12, 1999, through October 31, 1999, at an annual salary of $175,000 and
         became President November 1, 1999, at an annual salary of $225,000. Mr.
         Swart's  compensation  includes  $8,000  paid in  connection  with  his
         relocation to Portland, Oregon.

                                       10
<PAGE>

(5)      Mr. Swart received $16,830 in relocation expenses during 1999.

(6)      In 1998 Mr.  Ekberg served as Executive  Vice  President of the Company
         and in 1997 served as  Executive  Vice  President of  Acquisitions  and
         Development.

(7)      Mr. Jacobsen  resigned as an officer of the Company effective April 12,
         1999, but remained an employee  through June 30, 1999, and served as an
         independent  contractor to the Company through  September 30, 1999. The
         salary  disclosed  includes $67,500 paid to Mr. Jacobsen as an employee
         and $33,750 paid to him as an independent contractor.

         Employment Agreements.  Each officer of the Company has entered into an
employment  agreement with the Company.  The  employment  agreements for Messrs.
Bowen, Ekberg and Gish expire in December 2000. Mr. Swart's employment agreement
expires in March 2004. The agreements  generally entitle the officer to benefits
customarily  provided  by  the  Company  and  provide  for  a  base  salary  and
eligibility for a bonus.  The Company may terminate any officer without cause by
making to such  officer a cash  payment  equal to one year's  base salary at the
rate in  effect  at the time of  termination.  Any  officer  may  terminate  his
employment  upon 60 days' prior written  notice.  In addition,  each officer has
entered into a restrictive  covenant  agreement  containing  noncompetition  and
nondisclosure provisions.

         Stock  Option  Grants in Fiscal  1999.  There  were two grants of stock
options  made by the Company  during  fiscal 1999 to the officers of the Company
named in the Summary Compensation Table.
<TABLE>
<CAPTION>

                        Option Grants in Last Fiscal Year

- ------------------------------------------------------------------------------------------------------------------------------
                                                                                          Potential realizable value at
                                   Individual Grants                                      assumed annual rates of stock
                                                                                          price appreciation for option
                                                                                          term(2)
- ------------------------------------------------------------------------------------------------------------------------------
         Name           Number of       Percent of    Exercise    Market      Expir-          0%          5%          10%
                        securities          total        price    price on    ation          ($)          ($)         ($)
                        underlying        options      $/share    date of     date
                        options         granted to                grant
                        granted         employees
                                          in fiscal
                                            year(1)
- ----------------------- --------------- ------------- ----------- ----------- ----------- ----------- ----------- ------------
<S>                     <C>                <C>          <C>         <C>       <C>         <C>         <C>         <C>
Louis Swart             50,000(3)          18.5%        $4.625      $4.625    04/12/09         -0-     145,431    368,543
- ----------------------- --------------- ------------- ----------- ----------- ----------- ----------- ----------- ------------
Eric W. Jacobsen        75,000(4)(5)       27.8%        $3.00       $4.25     01/01/04      93,750     181,821    288,347
- ----------------------- --------------- ------------- ----------- ----------- ----------- ----------- ----------- ------------
Eric W. Jacobsen        25,000(4)(6)        9.3%        $4.00       $4.25     01/01/04       6,250      33,607     71,116
- ----------------------- --------------- ------------- ----------- ----------- ----------- ----------- ----------- ------------
</TABLE>

- ----------

(1)      The Company  granted a total of 270,000  options to  employees in 1999,
         including  100,000  options  granted  in  connection  with an  exchange
         discussed in the table below.

(2)      Future value of current year grants assuming appreciation of 0 percent,
         5 percent  and 10  percent  per year over the life of the  option.  The
         actual  value  realized  may be  greater  or less  than  the  potential
         realizable  values set forth in the table.  The assumed rates of growth
         are  prescribed  by  the  Securities  and  Exchange   Commission   (the
         "Commission")  for  illustrative  purposes only and are not intended to
         predict or forecast future stock prices.



                                       11
<PAGE>

(3)      The  options  have a term of ten  years  and  vest 20  percent  on each
         anniversary  of the grant.  Upon the  occurrence  of certain  corporate
         transactions, the exercisability of the options may be accelerated.

(4)      These shares were granted on February 16, 1999, in an exchange pursuant
         to which the  previously  issued  shares  were  cancelled.  See "Option
         Exchanges."

(5)      Sixty  percent of these options were vested upon  issuance,  20 percent
         vested on December  12,  1999,  and the  remaining 20 percent will vest
         December 12, 2000.

(6)      Forty  percent of these options were vested upon  issuance,  20 percent
         vested on November 18,  1999,  and 20 percent will vest on November 18,
         2000, and 2001, respectively.


         Option  Exercises  in 1999  and  Fiscal  Year-End  Option  Values.  The
following table sets forth  information (on an aggregated  basis) concerning the
fiscal year-end value of unexercised options held by each of the officers of the
Company  named in the Summary  Compensation  Table.  None of the officers  named
below exercised any stock options during fiscal 1999.
<TABLE>
<CAPTION>

                          Fiscal Year-End Option Values

                                                                         Value of Unexercised
                  Acquired              Number of Unexercised                In-the-Money
                     on       Value        Options at Year-End           Options at Year-End(1)
                                        -------------------------       -----------------------
Name              Exercise   Realized   Exercisable Unexercisable      Exercisable Unexercisable
- ----              --------   --------   ----------- -------------      ----------- -------------
<S>               <C>        <C>        <C>         <C>                <C>         <C>
Walter C. Bowen       --         --          --        --                   --          --
Louis Swart           --         --        -0-       50,000             $  -0-       $ -0-
James W. Ekberg       --         --      85,000(2)   40,000             $  -0-       $ -0-
Eric W. Jacobsen      --         --      75,000(3)   25,000             $  -0-       $ -0-
Steven L. Gish        --         --      43,000(3)   17,000             $  -0-       $ -0-
</TABLE>

- --------------------------

(1)      Options are "in-the  money" if the fair market value of the  underlying
         securities on that date exceeds the exercise  price of the option.  The
         amount set forth  represents  the  difference  between  the fair market
         value of the  securities  underlying  the options on December 31, 1999,
         based on the last sale price of $2.00 per share of Common  Stock on the
         date (as  reported on the  Over-the-Counter  Market)  and the  exercise
         price of the options, multiplied by the applicable number of options.

(2)      Does not include an option to purchase  50,000  shares of Common Stock,
         which is immediately exercisable at an exercise price of $6.00 a share,
         granted to Mr. Ekberg by Mr. Bowen in 1995.

(3)      Does not include an option to purchase  25,000  shares of Common Stock,
         which is immediately exercisable at an exercise price of $6.00 a share,
         granted to Mr. Gish by Mr. Bowen in 1995.


                                       12
<PAGE>
<TABLE>
<CAPTION>
                          Ten-Year Option / Repricings

- ----------------- ----------- ----------- ------------ ----------- ---------- --------------
          Name       Date     Securities  Market price   Exercise     New      Length of
                              underlying  of stock at     price at  exercise    Original
                              number of      time of      time of     price    option term
                                Options   repricing or   repricing     ($)     remaining at
                              repriced or   amendment       or                   date of
                              amended            ($)     amendment             repricing or
                                  (no.)                       ($)              amendment
- ----------------- ----------- ----------- ------------ ----------- ---------- --------------
<S>               <C>         <C>             <C>          <C>       <C>           <C>
James W. Ekberg   12/12/97    75,000(1)       $4.875       $7.50     $3.00         8 years
Senior Vice
  President of
  Finance and
  Development
- ----------------- ----------- ----------- ------------ ----------- ---------- --------------
Eric W. Jacobsen  12/12/97    75,000(1)       $4.875       $7.50     $3.00         8 years
Chief Operating
  Officer
- ----------------- ----------- ----------- ------------ ----------- ---------- --------------
Eric W. Jacobsen  02/16/99    75,000(2)       $4.25        $3.00     $3.00         7 years
Chief Operating
  Officer         02/16/99    25,000(2)       $4.25        $4.00     $4.00         8 years
- ----------------- ----------- ----------- ------------ ----------- ---------- --------------
Steven L. Gish    12/12/97    25,000(1)       $4.875       $7.50     $3.00         8 years
Chief Financial
  Officer
- ----------------- ----------- ----------- ------------ ----------- ---------- --------------
</TABLE>

(1)      On December 12, 1997, the Board of Directors approved the reissuance of
         certain options issued in connection with the Company's  initial public
         offering on December  26, 1995.  The same general  vesting and exercise
         periods were maintained in the exchange.

(2)      The terms of this grant are more particularly  described in footnotes 5
         and 6 to the above table  identified as "Options  Grants in Last Fiscal
         Year."


                Compensation Committee Report on Option Exchange

         In February 1999 the  Compensation  Committee of the Board of Directors
approved a plan to restructure  the employment  arrangement  with Eric Jacobsen,
the  Company's  then Chief  Operating  Officer.  A portion of this plan included
exchanging the options previously granted by the Company to Mr. Jacobsen for new
options  with the same  exercise  price  and  vesting  schedule.  The  principal
differences  between  the new and old  options  is that the new  options  expire
January 1, 2004,  instead of December 26, 2005 (75,000 options) and November 18,
2006  (25,000  options)  and the new  options  will  continue  to vest after Mr.
Jacobsen  leaves the employ of the Company and will not expire within 30 days of
that date. In  consideration  for this exchange,  Mr. Jacobsen  restructured his
employment  agreement  with  the  Company  which  the  Committee  deemed  to  be
sufficient consideration for the exchange described above.

Compensation Committee

Walter C. Bowen, Chair
Dana J. O'Brien
Gary Maffei




                                       13
<PAGE>

             Compensation Committee Report on executive compensation


         The Compensation  Committee of the Board (the "Committee")  consists of
Mr.  Bowen and two  independent  directors,  Messrs.  O'Brien  and  Maffei.  The
Committee is  responsible  for  establishing  and  administering  the  Company's
executive  compensation  programs.  The  objectives of these programs are to pay
competitively in order to attract  qualified  executive  personnel who best meet
the  Company's   needs;   retain  and  motivate  these   executives  to  achieve
performance; link individual compensation to individual and Company performance;
and  align   executives'   financial   interest  with  those  of  the  Company's
shareholders.

         Executive  compensation  generally  consists  of two  components:  base
salary and  long-term  incentive  awards.  The Committee  has  established  each
executive's  compensation  package by considering  (a) the salaries of executive
officers in similar  positions in companies in the same  industry as the Company
and in related  industries,  (b) the experience and  contribution  levels of the
individual  executive  officer,  and (c) the  Company's  financial  performance.
Companies used as a reference for considering  compensation  levels include some
but  not  all of  the  companies  constituting  the  peer  group  in  the  Stock
Performance  Graph. The Company also relies on the  recommendations of the Chief
Executive Officer in matters related to the individual  performance of the other
executive  officers,  because the Committee  believes  that the Chief  Executive
Officer  is the most  qualified  to make this  assessment.  Due to the  historic
performance of the Company's  common stock price,  and the low number of options
available  for grant to  executives  relative to those  available  at other peer
companies,  the Company  intends  for the base salary to be the primary  form of
compensation to its executives.

         Base  Salaries.  In 1999,  base salaries were  established as described
above.

         Stock  Options.  Stock  options  are  granted  to  provide a  long-term
incentive  opportunity  that is directly linked to shareholder  value.  They are
granted with an exercise  price equal to the market value of the common stock on
the date of the grant and  generally  become  exercisable  in 20 percent  annual
increments  beginning one year after the date of the grant.  To encourage  stock
retention,  all options are granted as  incentive  stock  options to the maximum
extent  possible  under the  Internal  Revenue  Code of 1986,  as  amended  (the
"Code").  In 1998,  stock options were granted to a total of 18 employees of the
Company in recognition of their position with the Company,  dedication, and hard
work. Only two of the named  executive  officers  received  options in 1999, one
related to being  newly  hired and the other  pursuant  to an  exchange  program
discussed above.

         Annual Incentives. To date, the Committee has not established a regular
annual incentive or bonus plan for the Company's executive officers. None of the
Company's named Executive Officers received a bonus in 1999.

         Other.  The Company has adopted a 401(k) Plan for all of its employees,
including Executive Officers, age 21 and over with at least one year of service.
The 401(k) Plan provides that each  participant  may contribute up to 20 percent
of his or her wages not to exceed the annual  statutory  limit. In general,  the
Company makes matching  contributions to each participant's  account equal to 50
percent  of  the   participant's   contribution  up  to  three  percent  of  the
participant's annual compensation.




                                       14
<PAGE>

         Chief Executive Officer's Compensation.  Mr. Bowen received a salary of
$250,000 in 1999 and 1998 and $200,000 in 1997 and participated in the Company's
401(k) Plan.  Mr. Bowen  currently  beneficially  owns  3,403,200  shares of the
Company's common stock, or 75.5 percent of the outstanding total. In view of his
stock ownership, Mr. Bowen has not received grants of stock options. The Company
reserves the right to make future grants of options to Mr. Bowen.

         Compensation  Deductibility  Policy.  Under Section 162(m) of the Code,
and  applicable  Treasury  regulations,  no  deduction  is  allowed  for  annual
compensation in excess of $1.0 million paid by a publicly traded  corporation to
its chief executive officer and the four other most highly compensated officers.
Under those provisions,  however, there is no limitation on the deductibility of
"qualified performance-based  compensation." In general, the Company's policy is
to maximize the extent of tax deductibility of executive  compensation under the
provisions  of  Section  162(m)  so long as  doing  so is  compatible  with  its
determinations as to the most appropriate  methods and approaches for the design
and delivery of compensation to the Company's executive officers.

Compensation Committee

Walter C. Bowen, Chair
Dana J. O'Brien
Gary Maffei



           COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION

         The Compensation Committee is comprised of two non-employee  directors,
Messrs. Maffei and O'Brien, and Mr. Bowen, who is the Chief Executive Officer.

         Mr.  Bowen  holds a 99  percent  general  partnership  interest  in the
Regency Park Apartments Limited Partnership ("Regency  Partnership"),  an Oregon
limited  partnership  from which the Company  leases its Regency Park  community
located in  Portland,  Oregon.  Mr.  Bowen  also  holds a 99  percent  ownership
interest in Sterling Park,  L.L.C., a Washington  limited liability company from
which the  Company  leases its  Sterling  Park  community  located  in  Redmond,
Washington.  Mr. Bowen's minor children hold the remaining one percent  interest
in the Regency  Partnership and Sterling Park, L.L.C. As a result, Mr. Bowen may
be deemed to receive the portion of the lease payments  remaining  after service
of the debt to which the properties are subject.  For 1999, these lease payments
were  $1,320,536  for Regency Park and  $1,486,248  for Sterling Park. For 1998,
these lease  payments  were  $1,312,400  for  Regency  Park and  $1,486,250  for
Sterling Park.

         Mr. Bowen holds a 90 percent interest in Desert Flower,  LLC, an Oregon
limited  liability company that owns the Desert Flower Assisted Living community
in  Scottsdale,  Arizona.  Mr.  Bowen's  minor  children  hold the remaining ten
percent interest in Desert Flower,  LLC. The Company developed the community and
sold it to  Desert  Flower,  LLC in a  transaction  through  which  the  Company
received proceeds of $1.2 million and Desert Flower, LLC assumed $8.8 million in
debt. The Company manages the community for Desert Flower, LLC, subject to a net
operating  income  guaranty  provided by the Company.  The Company  operated the
community  for two months  during  1999 as an owned  property  and  managed  the
community  for four months.  The Company  received  $18,300 in  management  fees
during this four month period.





                                       15
<PAGE>

         Bowen  Development  Company,  which  is  wholly  owned  by  Mr.  Bowen,
completed  construction  of  one of  the  Company's  new  communities  in  1999.
Additionally,  Bowen  Development  Company has  contracts  to complete  two more
communities  during 2000. Each of these projects is contracted for a fixed price
that includes  "contractor's  overhead and profit" which is paid on a percentage
of completion basis. Bowen Development Company earned approximately $526,000 for
contractor's  profit and overhead in 1999 on the three  projects.  The Company's
Conflicts  Committee or independent  directors  approved  these three  contracts
after  solicitation  and review of competitive  bids from  unaffiliated  general
contractors.

         The Company  believes  that each of the foregoing  transactions  was on
terms no less  favorable  to the  Company  than  could have been  obtained  from
unaffiliated  parties in  arm's-length  transactions;  however,  there can be no
assurance that such is the case.

         The Company and the Bowen  Companies  are all  controlled by Mr. Bowen.
Certain executive officers of the Company, including Messrs. Bowen and Gish, and
David R. Gibson,  the Company's  Vice President for Corporate  Affairs,  General
Counsel and  Secretary,  fulfill  similar  executive  functions  for other Bowen
Companies and spend  significant  amounts of time on the business of other Bowen
Companies.  The Company provides management and administrative  services to, and
from time to time may  obtain  services  or the use of certain  equipment  from,
certain of the Bowen Companies pursuant to an Administrative Services Agreement.
Under that agreement,  the Bowen Companies and the Company  reimburse each other
for the actual  cost of  services  received  under the  Administrative  Services
Agreement.  The Company  believes that the sharing of executive  management  and
other resources (such as data processing,  accounting,  legal,  financial,  tax,
treasury,  risk management and human resources) provides benefits to the Company
by  giving it access to a level of  experience  and  expertise  that can only be
supported by a larger  organization.  The  Administrative  Services Agreement is
cancelable by any party, including the Company, on 60 days' notice.  Pursuant to
the terms of the Administrative Services Agreement,  reimbursement of costs will
be reviewed at least annually by the Audit Committee of the Board of Directors.

         The  Administrative  Services Agreement requires the Bowen Companies to
offer first to the Company any opportunities  received by or originated with the
Bowen Companies  relating to the assisted living  business.  The  Administrative
Services  Agreement also requires all  transactions  between the Company and the
Bowen  Companies  to be on an  arm's  length  basis  containing  terms  no  less
favorable to the Company than could have been obtained  from an unrelated  third
party and  requires  any such  transaction  to be  approved by a majority of the
Company's  directors  unaffiliated  with the Bowen  Companies.  In 1999,  Regent
charged the Bowen Companies $78,000 under the Administrative Services Agreement.
In 1998,  Regent charged the Bowen Companies  $145,000 under the  Administrative
Services Agreement.

         As of March 31, 2000,  the Company has entered into  construction  loan
agreements in an aggregate  amount of $37,746,500  for the  construction  of its
Kenmore,   Vacaville,   Kent,   Corvallis,   South  Ogden,  Merced  and  Modesto
communities.  Repayment of each of these loans and  performance of the covenants
set forth in each loan is  personally  guaranteed  by Mr.  Bowen.  The Conflicts
Committee or the  independent  directors of the Company has approved the payment
of fees to Mr.  Bowen in the  aggregate  amount of $140,000 in exchange  for his
personal guaranty of the payment and performance relative to these loans.





                                       16
<PAGE>

                             STOCK PERFORMANCE GRAPH

         The following  graph compares the cumulative  total return on shares of
the Company's  Common Stock with the cumulative total return of the Standard and
Poor's Index 500 Stock, and a peer group index as defined below, from the period
beginning  on December  26,  1995,  the first day of trading  for the  Company's
Common Stock,  and ending on December 31, 1999,  the end of the  Company's  last
fiscal year.  The  Company's  stock began  trading on December 26, 1995,  at the
price of $7.50  per  share.  The graph  assumes  the  investment  of $100 in the
Company's  Common Stock,  the S&P500  Index,  and the Peer Group on December 26,
1995, and the reinvestment of dividends.  The Company has not paid any dividends
on its Common Stock during this period.


      COMPARISON OF CUMULATIVE TOTAL RETURN AMONG REGENT ASSISTED LIVING,
                   INC., THE S&P 500 INDEX, AND A PEER GROUP


                                [Graph Omitted}


<TABLE>
<CAPTION>
- ---------------------------- --------- --------- --------- --------- --------- ---------
                             12/26/95  12/31/95  12/31/96  12/31/97  12/31/98  12/31/99
- ---------------------------- --------- --------- --------- --------- --------- ---------
<S>                           <C>       <C>      <C>        <C>       <C>       <C>
Regent Assisted Living, Inc.  $100.00   $106.67  $ 63.33    $ 76.67   $ 66.67   $ 26.67
- ---------------------------- --------- --------- --------- --------- --------- ---------
S&P 500                        100.00    101.93   125.33     167.14    214.91    260.13
- ---------------------------- --------- --------- --------- --------- --------- ---------
Peer Group                     100.00     93.64   100.39     142.53    143.72     39.42
- ---------------------------- --------- --------- --------- --------- --------- ---------
</TABLE>


         Peer Group.  The peer group  index is  composed  of  selected  assisted
living  companies  whose core business and size are comparable to the Company's.
As the assisted living industry matures,  certain companies included in the peer
group may be removed as they become acquired or as their focus of services shift
away from the Company's core assisted living business.

         The  peer  group  consists  of the  following  ten  companies:  Alterra
Healthcare Corporation; American Retirement; ARV Assisted Living, Inc.; Assisted
Living  Concepts;  Balanced  Care Company;  Capital  Senior  Living;  CareMatrix
Corporation; Emeritus Corporation;  Greenbriar Corporation; and Sunrise Assisted
Living, Inc.


                                       17
<PAGE>

         SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

         The following table sets forth information,  as of March 31, 2000, with
respect  to the  beneficial  ownership  of the  Company's  Common  Stock by each
director or nominee for director, by each executive officer of the Company named
in the Summary  Compensation Table, by all directors and executive officers as a
group, and by each person who is known to the Company to be the beneficial owner
of more than five percent of the  Company's  outstanding  Common  Stock.  Unless
otherwise  indicated  in the Table,  each person has sole voting  power and sole
investment power with respect to all outstanding shares of Common Stock shown as
beneficially owned by them.

                                      Amount and Nature
 Name and Address of                    of Beneficial           Percent of
 Beneficial Owner(1)                      Ownership              Class(2)
- ---------------------                 -----------------         ----------

Walter C. Bowen                        3,403,200(3)                75.5%
Louis Swart                                -0-                       *
James W. Ekberg                          136,000(4)                 2.9%
Eric W. Jacobsen                          75,000                    1.6%
Steven L. Gish                            68,000(4)                 1.5%
Stephen A. Gregg                          64,500(5)                 1.4%
Marvin S. Hausman, MD                     36,000(5)(6)               *
Gary R. Maffei                            26,000(7)                  *
Dana J. O'Brien                            8,000(5)(8)               *
Wayne C. Rembold                           2,000(9)                  *

Prudential Private Equity
Investors III, L.P.
717 Fifth Avenue, Suite 1100
New York, NY  10022                    1,400,493(10)               23.7%

LTC Healthcare, Inc.
300 Esplanade Drive, Suite 1860
Oxnard, CA  93030                      1,133,333(11)               20.1%

All directors and executive officers
  as a group (11 persons)              3,818,700                   77.2%


* Less than one percent.

(1)      Unless  otherwise  indicated,  the address of each person  named is c/o
         Regent Assisted Living,  Inc., 121 S. W. Morrison  Street,  Suite 1000,
         Portland, Oregon 97204.

(2)      Assumes the exercise of solely that individual's options, or conversion
         of solely that  party's  underlying  instruments,  and  issuance by the
         Company of the related number of shares of Common Stock.

(3)      Includes  80,000  shares  held  of  record  by Mr.  Bowen  that  may be
         purchased  within 60 days by certain  officers and one other individual
         pursuant to options granted by Mr. Bowen. Mr. Bowen has granted options
         to purchase a portion of his shares to Messrs.  Ekberg (50,000  shares)
         and Gish (25,000 shares).



                                       18
<PAGE>

(4)      Includes shares that may be acquired within 60 days pursuant to options
         granted  by Mr.  Bowen to  purchase  a portion  of his shares and those
         shares  that may be  purchased  pursuant to options  granted  under the
         Company's 1995 Stock Incentive Plan.

(5)      Includes  8,000 shares that may be acquired  within 60 days pursuant to
         options granted under the Company's 1995 Stock Incentive Plan.

(6)      Includes  25,000 shares that may be acquired within 60 days pursuant to
         options granted under the Company's 1995 Stock Incentive Plan.

(7)      Includes  10,000 shares that may be acquired within 60 days pursuant to
         options granted under the Company's 1995 Stock Incentive Plan.

(8)      Does not include  shares of Series A or Series B Preferred  Stock owned
         by  Prudential  Private  Equity  Investors  III,  L.P.   ("PPEI"),   an
         investment fund managed by Cornerstone  Equity Investors,  L.L.C.,  the
         employer of Mr. O'Brien.

(9)      Includes  2,000 shares that may be acquired  within 60 days pursuant to
         options granted under the Company's 1995 Stock Incentive Plan.

(10)     Represents  the number of shares  that may be  acquired  within 60 days
         pursuant to the holder's right to convert its Series A Preferred  Stock
         into shares of Common Stock.  PPEI also owns 382,882 shares of Series B
         Preferred stock, each share of which can be converted into one share of
         Series A  Preferred  Stock or into a total of 417,690  shares of Common
         Stock upon the occurrence of specified conversion events.

(11)     This number  comprises the 1,133,333 shares that may be acquired by LTC
         Healthcare,  Inc.  within 60 days  pursuant to its right to convert its
         currently outstanding subordinated convertible notes into shares of the
         Company's Common Stock at a rate of $7.50 per share.


             SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

         Section  16(a) of the  Securities  Exchange  Act of 1934  requires  the
Company's  executive  officers,  directors,  and  persons  who own more than ten
percent  of the  outstanding  Common  Stock of the  Company  to file  reports of
ownership  and changes in  ownership  of the Common  Stock with the  Commission.
Executive officers, directors and greater than ten percent shareholders are also
required by  Commission  regulations  to furnish the Company  with copies of all
forms they file pursuant to Section 16(a).  Based solely on review of the copies
of such  reports  furnished  to the  Company and  written  representations  from
reporting  persons,  to the Company's  knowledge all of the Section 16(a) filing
requirements  applicable  to such persons  during fiscal year 1999 were complied
with on a timely basis.


                             DISCRETIONARY AUTHORITY

         Although  the Notice of Annual  Meeting of  Shareholders  provides  for
transaction of any other  business that properly  comes before the meeting,  the
Board of  Directors  has no  knowledge  of any  matters to be  presented  at the
meeting other than the matters  described in this proxy statement.  The enclosed
proxy,  however,  gives discretionary  authority to the proxy holders to vote in
accordance with their judgment if any other matters are presented.



                                       19
<PAGE>

         According to the rules of the Commission,  for the 2000 Annual Meeting,
if notice of a  shareholder  proposal  to be raised  at the  Annual  Meeting  is
received at the principal executive offices of the Company after March 13, 2000,
proxy voting on that proposal  when and if raised at the Annual  Meeting will be
subject to the  discretionary  voting authority of the designated proxy holders.
For the 2001 Annual Meeting of Shareholders, if notice of a shareholder proposal
to be raised at the meeting is received at the  principal  executive  offices of
the Company  after March 13,  2001,  proxy voting on that  proposal  when and if
raised at that  Annual  Meeting  will be  subject  to the  discretionary  voting
authority of the designated proxy holders.


                             INDEPENDENT ACCOUNTANTS

         PricewaterhouseCoopers  LLP audited the Company's financial  statements
for the year ended December 31, 1999.  Representatives of PricewaterhouseCoopers
LLP will be present at the Annual Meeting of Shareholders  and will be available
to respond to  appropriate  questions.  They do not expect to make any statement
but will have the opportunity to make a statement if they wish.

                              SHAREHOLDER PROPOSALS

         Any  shareholder  proposals  to be  considered  for  inclusion in proxy
material for the Company's  next Annual  Meeting in May 2001 must be received at
the principal executive office of the Company no later than December 31, 2000.

         A copy of Regent's 1999 Annual Report on Form 10-K will be available to
shareholders  without charge upon request to: Chief  Financial  Officer,  Regent
Assisted Living, Inc., 121 S. W. Morrison Street,  Suite 1000, Portland,  Oregon
97204.

                                            By order of the Board of Directors,



                                            David R. Gibson
                                            Secretary

April 28, 2000

<PAGE>
                          REGENT ASSISTED LIVING, INC.




   Proxy Solicited on Behalf of the Board of Directors of the Company for the
                         Annual Meeting on May 23, 2000




         The  undersigned  hereby names  Walter C. Bowen and Steven L. Gish,  or
either  of  them  acting  in the  absence  of the  other,  with  full  power  of
substitution,  my true and lawful  attorneys  and proxies for me in my place and
stead to attend the Annual Meeting of Shareholders  of Regent  Assisted  Living,
Inc. to be held on May 23, 2000, at 11:00 a.m.,  and any  adjournments  thereof,
and to vote all of the shares held in the name of the  undersigned  on March 31,
2000,  with all the powers  that the  undersigned  would  possess if  personally
present.

                                                            ----------------
                                                            SEE REVERSE SIDE
                                                            ----------------




                              FOLD AND DETACH HERE







<PAGE>


[ X ]   Please mark your votes
           as in this example

THIS PROXY IS SOLICITED BY THE BOARD OF DIRECTORS OF THE COMPANY. THE SHARES
REPRESENTED BY THIS PROXY WILL BE VOTED AS SPECIFIED BELOW, BUT IF NO
SPECIFICATION IS MADE, WILL BE VOTED FOR EACH OF THE NOMINEES NAMED IN PROPOSAL
1.

- ------------------------------------------------------------------------

          The Board of Directors unanimously recommends a vote FOR each
                         of the nominees listed below.
- ------------------------------------------------------------------------

                FOR  [   ]                           WITHHELD  [   ]

1.       Election of Directors                   Nominees:
         (Check only one box)                    Class 3 - Term Expiring in 2003
                                                 -------------------------------

         For all nominees (except as             Dana J. O'Brien
         Shareholder may indicate                Steven L. Gish
         below)

         ----------------------


                FOR  [   ]             AGAINST  [   ]          ABSTAIN  [   ]

2.       To amend the Company's 1995 Stock Incentive Plan to increase the number
         of shares of the Company's  Common Stock that may be issued pursuant to
         the plan from 600,000 to 800,000.

3.       In their  discretion,  the Proxies are  authorized  to consider and act
         upon any other matter which may properly come before the meeting or any
         adjournment thereof.
- --------------------------------------------------------------------------------


SIGNATURE(S)                                     DATE
            ---------------------------------        ---------------------------

Note:    Please sign exactly as name appears above. Joint owners should each
         sign. Fiduciaries should add their full title to their signature.
         Corporations should sign in full corporate name by an authorized
         officer. Partnerships should sign in partnership name by an authorized
         person.






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission